Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
Published . Updated .
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Korea National Institute of Health, located in Cheongju-si, Chungcheongbuk-do, South Korea to practice the invention embodied in the patent application listed in the Supplementary Information section of this notice.
Directly affected
- INTR Inter
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
- OAEM ONEASCENT ENHANCED SMALL AND MID CAP ETF INSTITUTIONAL SHS ONEASCENT EMERGI
GA selected OAEM as a RELATED security because its canonical security name directly matches this event's themes: institutional. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Korea Nation…
Source: Federal Register
How far Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM) has moved since 8 Oct 2026
Since the first closing price after “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof,” Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM) is -4.57%. The S&P 500 fund (SPY) is -1.53% over the same days, a -3.04% difference versus the market.
How busy Taiwan Strait has been lately
Taiwan Strait has 49 linked stories in the last 7 days and 49 in the last 30 on the page that also carries “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof.” The recent pace is rising.
Who gains and who loses around Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM)
Companies carried with this story
- OAEM Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi
For “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof,” Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM) is linked, with no stored direction, medium confidence. Reason on file: GA selected OAEM as a RELATED security because its canonical security name directly matches this event's themes: institutional. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
What Taiwan Strait means for Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM)
Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM) is the company in “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof,” the 8 Oct 2026 Taiwan Strait story.
For Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM), the reason on file says GA selected OAEM as a RELATED security because its canonical security name directly matches this event's themes: institutional. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM) price range
OAEM traded between 46.86 and 50.53 across 19 sessions. The latest close on file is 47.20.
A simple score for Oneascent Enhanced Small And Mid Cap Etf Institutional Shs Oneascent Emergi (OAEM)
22 out of 100
“Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof” scores 22 out of 100. The score uses 2 sources, and 1 linked companies.